Related references
Note: Only part of the references are listed.Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide-1 Receptor Agonist
John D. Bucheit et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Oral semaglutide in type 2 diabetes
Sarah L. Anderson et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Promoting apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient -absorption pathway
Lei Wu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date
Christina Antza et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery
Jiawei Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery
Weiwei Fan et al.
BIOMATERIALS (2018)
Diabetes, cardiovascular disease and the microcirculation
W. David Strain et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway
Yaxian Zheng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs
Lei Wu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice
Na Wang et al.
SCIENTIFIC REPORTS (2017)
Fundamental studies on throughput capacities of hydrodynamic flow-focusing microfluidics for producing monodisperse polymer nanoparticles
Thejus Baby et al.
CHEMICAL ENGINEERING SCIENCE (2017)
Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects
Joel Richard
THERAPEUTIC DELIVERY (2017)
Cholesterol-modified poly(lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery
Jeong-Jun Lee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Liraglutide for Type 2 diabetes and obesity: a 2015 update
Eva Winning Iepsen et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
Early liraglutide treatment is better in glucose control, β-cell function improvement and mass preservation in db/db mice
Yimin Shao et al.
PEPTIDES (2014)
pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery
Hong Wu et al.
BIOMATERIALS (2013)
The Cardiovascular Effects of GLP-1 Receptor Agonists
Theodore Okerson et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Novel GLP-1 receptor agonists for diabetes
Alan J. Garber
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Preparation and characterization of self-assembled nanoparticles of 6-O-cholesterol-modified chitosan for drug delivery
Mingmao Chen et al.
CARBOHYDRATE POLYMERS (2011)
The N-terminal Domain of NPC1L1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol Uptake
Jin-Hui Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease
J. David Spence et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Synchronizing Ca2+ and cAMP oscillations in pancreatic beta-cells: a role for glucose metabolism and GLP-1 receptors? Focus on Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach
George G. Holz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Intestinal cholesterol transport proteins: an update and beyond
Emile Levy et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review
C. M. Bennett et al.
DIABETIC MEDICINE (2007)
Localization and role of NPC1L1 in cholesterol absorption in human intestine
Alain Theophile Sane et al.
JOURNAL OF LIPID RESEARCH (2006)
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Vassilis I. Zannis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Liver disease in patients with diabetes mellitus
SA Harrison
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Fat in the liver and insulin resistance
H Yki-Jarvinen
ANNALS OF MEDICINE (2005)
The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes
JB Buse et al.
DIABETES OBESITY & METABOLISM (2004)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
GLP-1 receptor agonists are growth and differentiation factors for pancreatic istet beta cells
JM Egan et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands
T Ohama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Cellular localization and trafficking of the human ABCA1 transporter
EB Neufeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
N Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
